GMO TECH Holdings (415A) · TargetRestated
FY2028 sales of ¥16 billion and operating profit of ¥2 billion, and a move to the Prime Market in FY2029
First written in FY2025. 3 of 5 entries say "Restated". Latest entry: 2026-08-13.
5entries
1years
3from disclosures
How it moved
Same theme, other companies
Setting and Achieving Earnings Targets Under the Medium-Term Management PlanA theme 786 companies write about · 73 as a headwind · 1057 as a tailwind
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1175 threads.Full recordFilings, disclosures and news, newest first
- 2026-08-13RestatedEarnings
「We have not changed the full-year earnings forecast for the fiscal year ending December 2026 announced on 12 February 2026.」
通期業績予想を変更しておらず、2028年12月期の中期経営計画目標についても、トライハッチ買収の説明で引き続き言及している。 - FY2026-H1RestatedAnnual report
「We have not changed the full-year earnings forecast for the fiscal year ending December 2026 announced on 12 February 2026.」
The company confirmed that there had been no material changes to the assumptions underlying its full-year earnings forecast and medium-term management plan. - FY2025First statedAnnual report
「For FY2028, the final year of this plan, we have set targets of ¥16 billion in net sales and ¥2 billion in operating profit. We have also set a target of transferring to the Prime Market segment in FY2029.」
Numerical targets and a market-segment transfer target under the medium-term management plan covering FY2026 through FY2028.